Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Preventing Bone Loss by Targeting Endothelial Cell-Tissue Crosstalk

Project description

Endothelial cells for osteoporosis treatment

In healthy ageing and osteoporosis, mineralised bone loss results from an imbalance between bone formation and resorption. Additionally, there is limited knowledge about the impact of sex-specific regulators on normal and disrupted bone balance. Recent research has identified a new type of blood vessel in bone (type R) that plays a role in bone turnover. The ERC-funded PROTECT project will study the role of endothelial cells and type R capillaries in maintaining bone health and preventing bone loss. It will create new mouse models, examine molecular regulators, and investigate sex-specific and age-related factors affecting bone homeostasis. The results will lay the groundwork for future treatments involving endothelial cells.

Objective

During healthy aging but also in osteoporosis, a disease that affects more than 22% of European women beyond the age of 50, loss of mineralized bone is caused by a disbalance between bone formation and resorption. While blood vessels are abundant in the skeletal system and play essential roles, they are currently not considered in the context of anti-osteoporosis therapy. Moreover, apart from the role of sex hormones, we know too little about the impact of sex-specific regulators in physiological and disturbed bone homeostasis. Our recent work has provided fundamental insights into the organization of the bone vasculature in mouse, the heterogeneity and functional specialization of endothelial cells (ECs), and the changes during aging. Recent and unpublished research from my team has utilized single cell RNA sequencing in combination with advanced immunostaining and imaging to identify a novel EC subpopulation (termed type R for remodeling). Type R vessels are post-arterial capillaries found at sites of homeostatic and therapeutic bone turnover, mainly trabecular bone, and their activation in young mice can enhance osteogenesis. In aging mice type R vessel clusters emerge inside cortical bone at sites of bone loss. PROTECT will systemically characterize the function of ECs and, in particular, type R capillaries in healthy homeostasis and during bone loss. This will involve the generation of new mouse lines for intersectional genetics and the characterization of critical molecular regulators. We will also characterize sex-specific and age-related factors controlling bone homeostasis and employ approaches to translate our findings into the human system. Preclinical experiments in mice will establish whether ECs and type R capillaries are involved in the response to therapies aiming at osteoblasts or osteoclasts. PROTECT will generate the conceptual basis for future approaches utilizing endothelial cells for the prevention of bone loss and anti-osteoporotic therapy.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-ADG

See all projects funded under this call

Host institution

MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Net EU contribution
€ 2 498 719,00
Address
HOFGARTENSTRASSE 8
80539 MUNCHEN
Germany
Region
Berlin Berlin Berlin
Activity type
Research Organisations
Links
Total cost
€ 2 498 719,00

Beneficiaries (1)